{
    "clinical_study": {
        "@rank": "14964", 
        "acronym": "RECRUIT", 
        "arm_group": [
            {
                "arm_group_label": "RECRUIT intervention", 
                "arm_group_type": "Experimental", 
                "description": "Clinical sites will work with the RECRUIT team to enhance and individualize their recruitment methods."
            }, 
            {
                "arm_group_label": "Control", 
                "arm_group_type": "Experimental", 
                "description": "Clinical sites can use which ever recruitment methods they prefer."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to test a recruitment intervention to increase racial/ethnic\n      diversity in clinical trials. The trial will be conducted in clinics where community\n      physician referrals are needed. Recruitment approaches cannot be made directly to community\n      members.  Minorities as defined in this trial include those underrepresented in clinical\n      trials:\n\n        -  African Americans/ Blacks\n\n        -  Asians\n\n        -  Native Hawaiians/Other Pacific Islanders\n\n        -  Hispanic/Latinos\n\n        -  Native Americans/Alaskan Natives"
        }, 
        "brief_title": "A Recruitment Intervention Trial", 
        "completion_date": {
            "#text": "June 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Recruitment of Minorities", 
        "detailed_description": {
            "textblock": "Low minority participation in clinical trials limits our ability to assess and address\n      potential differences in therapeutic responses. To address the problem of low minority\n      recruitment we are initiating a randomized trial of a recruitment intervention (RECRUIT)\n      funded by the National Institute on Minority Health and Health disparities (NIMHD) to\n      increase racial/ethnic diversity in clinical trials.\n\n      Our specific approach is directed toward multisite trials conducted at specialty clinics in\n      academic centers with recruiting venues that include community practices or practices of\n      colleagues in other areas of the academic center. The intervention will focus on\n      approximately 60 specialty clinics. Clinical sites will be randomized to the intervention or\n      control group. The target of the intervention will be the site investigators and clinical\n      trial coordinators."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion:\n\n        A parent trial must :\n\n          -  have a coordinating Center willing to allow their Clinical Sites to participate;\n\n          -  be studying be studying a condition that requires community or health system\n             physician referral\n\n          -  be studying an intervention where the recruitment approach cannot be made directly to\n             minority community members\n\n          -  need to increase recruitment of racially/ethnically diverse participants* to the\n             trial as demonstrated by current trial progress or historical data from other trials\n             in the same disease;\n\n          -  be a Phase II or Phase III trial\n\n          -  be conducted in at least six multiple sites;\n\n          -  expect each Clinical Site to recruit at least 10 participants;\n\n          -  be funded by a sponsor (NIH or pharmaceutical company or other) that has a strong\n             commitment to recruiting racially/ethnically diverse subjects;\n\n          -  be willing to have investigators and coordinators attend a special training meeting\n             (at RECRUIT expense);\n\n          -  require randomization to intervention or control (could be best medical care or\n             active control or placebo or other type of control);\n\n          -  provide transportation costs for trial participants who need assistance in getting to\n             trial sites or use some RECRUIT reimbursement for this purpose.\n\n        The clinical site must\n\n          -  be a funded Clinical Site in the parent trial;\n\n          -  be located in an area where at least 20% of the population within 30 miles in the age\n             group under study in the parent trial are from diverse populations.\n\n        Exclusion Criteria:\n\n          -  site does not agree to be randomized;\n\n          -  investigator or coordinator is under 18 years of age."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "85 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 24, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01911208", 
            "org_study_id": "NIMHD006941", 
            "secondary_id": "U24MD006941"
        }, 
        "intervention": [
            {
                "arm_group_label": "RECRUIT intervention", 
                "description": "Sites randomized to RECRUIT are taught skills to develop a tailored recruitment intervention encompassing continuous quality improvement and patient navigation.", 
                "intervention_name": "RECRUIT intervention", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": "Control", 
                "description": "Non-intervention control.", 
                "intervention_name": "Control", 
                "intervention_type": "Behavioral"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Minority", 
            "Recruitment"
        ], 
        "lastchanged_date": "March 4, 2014", 
        "location": {
            "contact": {
                "last_name": "Rossybelle Amorrortu, MPH", 
                "phone": "713-500-9577"
            }, 
            "facility": {
                "address": {
                    "city": "Houston", 
                    "country": "United States", 
                    "state": "Texas", 
                    "zip": "77030"
                }, 
                "name": "University of Texas Health Science Center School of Public Health"
            }, 
            "investigator": {
                "last_name": "Barbara C. Tilley, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Randomized Recruitment Intervention Trial", 
        "overall_contact": {
            "email": "recruit@uth.tmc.edu", 
            "last_name": "Rossybelle Amorrortu, MPH"
        }, 
        "overall_official": {
            "affiliation": "The University of Texas Health Science Center, Houston", 
            "last_name": "Barbara C. Tilley, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Institutional Review Board", 
                "United States: Federal Government"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Minorities as defined in this trial include those underrepresented in clinical trials and considered underrepresented by NIH criteria with the addition of those of Asian descent.", 
            "measure": "Percentage of racially/ethnically diverse participants (minorities) enrolled", 
            "safety_issue": "No", 
            "time_frame": "Up to 2 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01911208"
        }, 
        "responsible_party": {
            "investigator_affiliation": "The University of Texas Health Science Center, Houston", 
            "investigator_full_name": "Barbara Tilley", 
            "investigator_title": "SPH Faculty - Biostatistics", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Differences between intervention and control sites in number of participant referrals.", 
                "measure": "Number of participant referrals", 
                "safety_issue": "No", 
                "time_frame": "up to 2 years"
            }, 
            {
                "description": "Numbers and types of activities reported on recruitment logs by all sites.", 
                "measure": "Recruitment Activities", 
                "safety_issue": "No", 
                "time_frame": "up to 2 years"
            }, 
            {
                "description": "Change from baseline in physician investigator and coordinator outcome expectations (intervention sites only).", 
                "measure": "Investigator and Coordinator Outcome expectations", 
                "safety_issue": "No", 
                "time_frame": "up to 2 years"
            }, 
            {
                "description": "Qualitative key informant phone interviews of the physician investigators and coordinators (intervention and control sites).", 
                "measure": "Qualitative Key Informant Interviews", 
                "safety_issue": "No", 
                "time_frame": "up to 2 years"
            }, 
            {
                "description": "Potential/enrolled participant satisfaction with intervention and control trial site investigators and coordinators. Subjects will be given a satisfaction survey at screening and at every follow up visit.", 
                "measure": "Participant Satisfaction", 
                "safety_issue": "No", 
                "time_frame": "up to 2 years"
            }, 
            {
                "description": "Change from baseline in physician investigator and coordinator self-efficacy(intervention sites only).", 
                "measure": "Investigator and Coordinator Self-Efficacy", 
                "safety_issue": "No", 
                "time_frame": "up to 2 years"
            }
        ], 
        "source": "The University of Texas Health Science Center, Houston", 
        "sponsors": {
            "collaborator": {
                "agency": "National Center on Minority Health and Health Disparities (NCMHD)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "The University of Texas Health Science Center, Houston", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}